Next Article in Journal
Cerebral Blood Flow Regulation in Pregnancy, Hypertension, and Hypertensive Disorders of Pregnancy
Next Article in Special Issue
Effects of High Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) on Delay Discounting in Major Depressive Disorder: An Open-Label Uncontrolled Pilot Study
Previous Article in Journal
Effects of Transpulmonary Administration of Caffeine on Brain Activity in Healthy Men
Previous Article in Special Issue
Entropy Analysis of High-Definition Transcranial Electric Stimulation Effects on EEG Dynamics
Open AccessArticle

A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes

Laboratory for Pathology Dynamics, Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA 30332, USA
*
Author to whom correspondence should be addressed.
Brain Sci. 2019, 9(9), 223; https://doi.org/10.3390/brainsci9090223
Received: 30 June 2019 / Revised: 27 August 2019 / Accepted: 31 August 2019 / Published: 4 September 2019
(This article belongs to the Collection Collection on Clinical Neuroscience)
There is literature discord regarding the impact of percutaneous endoscopic gastrostomy (PEG), or “feeding tube”, on amyotrophic lateral sclerosis (ALS) outcomes. We assess one of the largest retrospective ALS cohorts to date (278 PEG users, 679 non-users). Kruskal–Wallis and Kaplan–Meier analysis compared cohort medians and survival duration trends. A meta-analysis determined the aggregate associative effect of PEG on survival duration by combining primary results with 7 published studies. Primary results (p < 0.001) and meta-analysis (p < 0.05) showed PEG usage is associated with an overall significant increase in ALS survival duration, regardless of onset type. Percent predicted forced vital capacity (FVC %predict) ≥50 at PEG insertion significantly increases survival duration (p < 0.001); FVC %predict ≥60 has the largest associative benefit (+6.7 months, p < 0.05). Time elapsed from ALS onset until PEG placement is not predictive (p > 0.05). ALSFRS-R survey assessment illustrates PEG usage does not slow functional ALS pathology (p > 0.05), but does stabilize weight and/or body mass index (BMI) (p < 0.05). Observed clinical impression of mood (CIM), was not impacted by PEG usage (p > 0.05). Overall results support PEG as a palliative intervention for ALS patients with ≥50 FVC %predict at PEG insertion. View Full-Text
Keywords: ALS; motor neuron disease; dysphagia; malnutrition ALS; motor neuron disease; dysphagia; malnutrition
Show Figures

Graphical abstract

MDPI and ACS Style

Bond, L.; Ganguly, P.; Khamankar, N.; Mallet, N.; Bowen, G.; Green, B.; Mitchell, C.S. A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes. Brain Sci. 2019, 9, 223.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop